Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications-Reference-Cited by-同舟云学术

Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications

Published:2017-09 Issue:Supplement 2 Volume:58 Page:10S-16S
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Reubi Jean Claude,Maecke Helmut R.

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference54 articles.

1. Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management;Ito;Curr Opin Endocrinol Diabetes Obes.,2017

2. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

3. Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

4. Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands

5. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards Effective Targeted Alpha Therapy for Neuroendocrine Tumours: A Review;Pharmaceuticals;2024-03-04

2. Precision peptide theranostics: developing N- to C-terminus optimized theranostics targeting cholecystokinin-2 receptor;Theranostics;2024

3. Membrane and Nuclear Absorbed Doses from¹⁷⁷Lu and¹⁶¹Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study;Journal of Nuclear Medicine;2023-06-15

4. Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists;Pharmaceuticals;2023-04-30

5. Modular One-Pot Strategy for the Synthesis of Heterobivalent Tracers;ACS Medicinal Chemistry Letters;2023-04-21